An Assessment of the Health System Impacts of Direct-To-Consumer Advertising of Prescription Medicines. Vol. I

AuthorsMintzes B, Barer ML, Kazanjian A, Bassett K, Evans RG, Morgan S
SourceExecutive Summary.
Vancouver (BC): Centre for Health Services and Policy Research; February 2002. (11 pages)
Évaluation des effets, sur le système de santé, de la publicité des médicaments de prescription orientée directement vers le consommateur (PODC): Tome I: Résumé. février 2002. (13 pages)
AbstractThe aim of this project was to identify and assess potential impacts of direct-to-consumer prescription drug advertising (DTCA) on health care delivery in Canada, estimate the costs of these impacts and consider potential risks and benefits, in terms of health consequences. This two-year project ran from September 1, 1999 – August 31, 2001. It was funded through Health Canada’s Health Transition Fund.

The project has four main components:
* A literature review of empirical studies published between 1990 and 2000;
* A comparative patient/doctor survey in physicians' offices in Vancouver and Sacramento, assessing the impact of patient requests for medicines on prescribing;
* An opinion survey of drug policy experts in Canada, the US and New Zealand;
* An economic analysis of DTCA in terms of consumer welfare models for advertising.
CodeHPRU 02:01D

a place of mind, The University of British Columbia

UBC Centre for Health Services and Policy Research
201 - 2206 East Mall, Vancouver BC, V6T 1Z3
Tel: 604.822.4969
Fax: 604.822.5690
E-mail: enquire@chspr.ubc.ca

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia